| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-06 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.26 |
3e-06 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.27 |
3e-06 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
5e-06 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
6e-06 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
6e-06 |